Gossamer Bio

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Gossamer Bio and other ETFs, options, and stocks.

About GOSS

Gossamer Bio, Inc. engages in discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. Its primary product candidate, GB001, is intended for the treatment of moderate-to-severe eosinophilic asthma and other allergic conditions. 

CEO
Faheem Hasnain
CEOFaheem Hasnain
Employees
162
Employees162
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
2015
Founded2015
Employees
162
Employees162

GOSS Key Statistics

Market cap
38.96M
Market cap38.96M
Price-Earnings ratio
-0.22
Price-Earnings ratio-0.22
Dividend yield
Dividend yield
Average volume
13.31M
Average volume13.31M
High today
$0.1809
High today$0.1809
Low today
$0.164
Low today$0.164
Open price
$0.179
Open price$0.179
Volume
14.27M
Volume14.27M
52 Week high
$3.87
52 Week high$3.87
52 Week low
$0.1626
52 Week low$0.1626

Stock Snapshot

Gossamer Bio(GOSS) stock is priced at $0.18, giving the company a market capitalization of 38.96M. It carries a P/E multiple of -0.22.

During the trading session on 2026-06-08, Gossamer Bio(GOSS) shares reached a daily high of $0.18 and a low of $0.16. At a current price of $0.18, the stock is +8.5% higher than the low and still -1.7% under the high.

Trading volume for Gossamer Bio(GOSS) stock has reached 14.27M, versus its average volume of 13.31M.

Over the past 52 weeks, Gossamer Bio(GOSS) stock has traded between a high of $3.87 and a low of $0.16.

Over the past 52 weeks, Gossamer Bio(GOSS) stock has traded between a high of $3.87 and a low of $0.16.

GOSS News

TipRanks 4d
Gossamer Bio Restructures Capital Through Convertible Notes Exchange - TipRanks

...

Gossamer Bio Restructures Capital Through Convertible Notes Exchange - TipRanks
TipRanks 5d
Gossamer Bio announces early tender results, early settlement of solicitation

Gossamer Bio (GOSS) announced the early tender results of its previously announced exchange offer to exchange any and all of its 5.00% Convertible Senior Notes...

TipRanks 6d
Gossamer Bio Extends Early Deadline in Note Exchange

Unlock trusted, data-backed investing tools with TipRanks Premium, from analyst ratings and forecasts to breaking news and portfolio analysis. Discover high-co...

Analyst ratings

57%

of 7 ratings
Buy
28.6%
Hold
57.1%
Sell
14.3%

People also own

Based on the portfolios of people who own GOSS. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.